Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02474680 · ClinicalTrials.gov registry record
Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes
A clinical trial, sponsored by Avera McKennan Hospital & University Health Center.
- Completed
- Registry status
- 84
- Enrollment target
NCT02474680 is a clinical trial that has completed, run by Avera McKennan Hospital & University Health Center. The registered enrollment target is 84 participants.
The verdict
NCT02474680 has completed, sponsored by Avera McKennan Hospital & University Health Center.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
This is a non-randomized, single-case design of pharmacogenetic implementation in a mental health patient population of subjects taking antipsychotics and/or antidepressants.
Interventions
- GENETIC Pharmacogenetic testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2015-11-01 |
| Est. Completion | 2017-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02474680
The ClinicalTrials.gov registry entry for NCT02474680 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avera McKennan Hospital & University Health Center, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pharmacogenetic testing is the first listed.
NCT02474680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02474680 about?
NCT02474680 is a clinical study titled "Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes". This is a non-randomized, single-case design of pharmacogenetic implementation in a mental health patient population of subjects taking antipsychotics and/or antidepressants.
What is the current status of trial NCT02474680?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2015-11-01. Estimated completion is 2017-01-01.
What interventions are being tested in trial NCT02474680?
The interventions under investigation include: Pharmacogenetic testing (GENETIC).
Who is sponsoring clinical trial NCT02474680?
This trial is sponsored by Avera McKennan Hospital & University Health Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.